REG - Arix Bioscience Plc - Director/PDMR Shareholding

Arix BioscienceAnnouncement

04/05/2023 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230504:nRSD4854Ya&default-theme=true

RNS Number : 4854Y  Arix Bioscience Plc  04 May 2023

Arix Bioscience plc

("Company")

PDMR notifications & Director Shareholdings

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

The Company has been notified that Robert Lyne, Chief executive Officer, has
sold a total of 107,657 Ordinary shares of 0.001 pence each in the Company
("Shares") on 04 May 2023 at an average price of 105 pence per share and
bought on 04 May 2023, into his ISAs and SIPP, a total of 107,657 Shares at an
average price of 107 pence per share.

The notification below, made in accordance with the requirements of UK Market
Abuse Regulation, provides further detail on the respective transactions.

 1     Details of the person discharging managerial responsibilities / person closely

     associated

 a)    Name                                                         Robert Lyne

 2     Reason for the notification

 a)    Position/status                                              Chief Executive Officer

 b)    Initial notification /Amendment                              Initial Notification

 3     Details of the issuer, emission allowance market participant, auction

     platform, auctioneer or auction monitor

 a)    Name                                                         Arix Bioscience plc

 b)    LEI                                                          213800OVT3AHQCXNIX43

 4     Details of the transaction(s): section to be repeated for (i) each type of

     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the financial instrument, type of instrument  Arix Bioscience plc Ordinary shares of 0.001 pence each

       Identification code                                          GB00BD045071
 b)    Nature of the transaction                                    Share Disposal

  c)   Price(s) and volume(s)                                                         Price(s)£                  Volume(s)
                                                                                      1.)      £1.052            22,238

                                                                                                                 20,000

                                                                                      2.)       £1.053           8,419

                                                                                                                 57,000

                                                                                      3.)       £1.0526

                                                                                      4.)       £1.0425

 d)    Aggregated information

       - Aggregated volume                                           107,657
       - Price (£)                                                   £112,669.14
 e)    Date of the transaction                                      4 May 2023

 f)    Place of the transaction                                     London Stock Exchange

 

 1     Details of the person discharging managerial responsibilities / person closely

     associated

 a)    Name                                                         Robert Lyne

 2     Reason for the notification

 a)    Position/status                                              Chief Executive Officer

 b)    Initial notification /Amendment                              Initial Notification

 3     Details of the issuer, emission allowance market participant, auction

     platform, auctioneer or auction monitor

 a)    Name                                                         Arix Bioscience plc

 b)    LEI                                                          213800OVT3AHQCXNIX43

 4     Details of the transaction(s): section to be repeated for (i) each type of

     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the financial instrument, type of instrument  Arix Bioscience plc Ordinary shares of 0.001 pence each

       Identification code                                          GB00BD045071
 b)    Nature of the transaction                                    Share Purchase

  c)   Price(s) and volume(s)                                                         Price(s)(£)       Volume(s)
                                                                                      £1.069            57,014

                                                                                      £1.069            8,419

                                                                                      £1.068            42,224

 d)    Aggregated information

       - Aggregated volume                                            107,657
       - Price (£)                                                    £115,094.42
 e)    Date of the transaction                                      4 May 2023

 f)    Place of the transaction                                     London Stock Exchange

 

Ends.

For further information please contact:

Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHQZLFBXELBBBB